Exchange: NASDAQ·Updated 07:30 PM EDT
SVRA logo

SVRA Savara Inc

$5.37
$0.09
(1.65%)
Today
Closed $5.37
$0.00
(0.00%)
After Hours
Reported EarningsAug 11
Mkt Cap$1.12B
Vol1.24M

About SVRA

Savara, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. Its program includes molgramostim, which is an inhaled formulation of recombinant human GM-CSF and being developed for the treatment of autoimmune pulmonary alveolar proteinosis. The company was founded in December 1995 and is headquartered in Langhorne, PA.
39

Bearish Sentiment

How do you feel about SVRA?

Advertisement|Remove ads.